Professional Documents
Culture Documents
EMC 023 May2012 Summary
EMC 023 May2012 Summary
COM
Bedside ED Ultrasound:
ED U/S for ectopic is very specific for
How should we manage stable
ruling out ectopic (6), and involves
patients with miscarriage?
looking for intrauterine pregnancy
Management options are expectant (IUP), and free fluid in the pelvis and
management, medical management abdomen. To confirm an IUP by U/S, a
(misoprostol 800mg inserted vaginally decidual reaction with a gestational sac
encourages passage of products), and Ectopic Pregnancy and yolk sac (+/- fetal pole) must be
surgical management (D&C). seen *within* the uterus. Even if an IUP
Only 50% of patients have classic risk
Counseling in the ED must also address factors (past history of ectopic, tubal is seen, if the patient is unstable with
psychological concerns: surgery, tubal ligation, infertility free fluid in the abdomen, it may be a
treatment, or PID). The classic triad of ruptured cyst or a “heterotopic”!
- use sensitivity and empathy,
abdominal pain (80–90%), missed When to give Rhogam: Give Anti-
- acknowledge distress and grief, menses 4–12 wks after LMP (75–90%) D immunoglobulin to non sensitized Rh-
- reassure the patient that neither she & vaginal bleeding (50–80%) is NOT D negative women to prevent
nor her partner did anything to cause sensitive. Up to 25% lack the full triad, development of RhD antibodies. It
the miscarriage, and and 10% may have no symptoms. should be given as soon as possible after
Consider ectopic when a patient presents the immunizing event (within 72 hours)
- there is no increased risk for future
with syncope and has a positive BhCG. and effects last for 12 weeks.
miscarriages (if < 3 have occurred).
How are ectopic pregnancies treated and what are the
complications that may occur?
Treatment options for Molar Pregnancy
ectopic pregnancy What is a molar pregnancy: E C TOP I C P I TFAL LS
Expectant: in stable patients with a Molar pregnancies are tumors from
BhCG below 200 and not increasing, abnormal fertilization of an ovum, with
>75% will resolve spontaneously. Close overproliferation of trophoblastic tissue.
monitoring is needed until BhCG <15. A complete mole has no fetal tissue,
while an incomplete mole has abnormal
Methotrexate (MTX): MTX is a fetal tissue.
folic acid antagonist that is up to 95%
effective in appropriate patients (BhCG Most common presentation is
<5000, no fetal cardiac activity, ectopic vaginal bleeding, but they can
mass <3–4cm, hemodynamically stable, present with ovarian torsion due
AVOID these major pitfalls of
no sign of rupture, reliable patient.) to generation of reactive cysts.
diagnosing ectopic pregnancy in the
The uterus will be larger than dates, and
Failure of MTX is related to BhCG level: emergency department:
ultrasound may show a “snowstorm”
Failure rates are approx. 15% with BhCG appearance. Ultrasound is not sensitive • assuming low BhCG rules out
>5000 and 5% with BhCG <5000. for molar pregnancy in first trimester. ectopic
Prior to MTX treatment, blood tests must • relying on the “classic triad”
confirm normal liver and kidney function, and
patients must be counseled to avoid folic • relying on inexperienced
ultrasonographer or non-hospital
acid and alcohol. Strenuous exercise and
ultrasound lab reports
intercourse must also be avoided due to the
risk of tubal rupture. Patients must also • assuming no products of
discontinue folic acid supplementation. conception seen on U/S means it
Patients may present with preeclampsia was a complete abortion (and not
Surgical: for patients who do not
and/or hyperthyroid symptoms due to an ectopic)
qualify for or have failed other
very high BhCG levels (>100,000). • failure to appreciate degree of
management, or patients who have intra-
abdominal bleeding or are unstable, Treatment is surgery, and blood loss
surgical management is indicated. includes a workup for metastatic
• failure to consider heterotopic* if
disease. 15–20% of complete molar unstable and IUP seen on U/S
pregnancies and 2% of incomplete
If a patient who received MTX become neoplastic, so patients need a • failure to assure adequate follow
returns with abdominal pain: CXR and liver enzyme measurements, up if no IUP is seen or if the
ultrasound is indeterminate
Abdominal pain is a common side effect and close follow-up with OB/GYN.
of MTX treatment, but may indicate tube *heterotopic risk of 1 in 30,000
rupture (occurs in 4% of patients, usually pregnancies rises to 1 in 100 if the
References: patient is receiving fertility treatments
2 weeks after MTX treatment). Patients
need a full workup for ectopic rupture: 1) Minnerop et al. Am J Emerg Med. 2011;
hematocrit, BhCG, and ultrasound to 29:212
look for bleeding. If there are any signs 2) Ramoska et al. Ann Emerg Med. 1989;18:48
of rupture, urgent OB consult is needed. 3) Buckley et al. Ann Emerg Med. 2000;36:95
**Due to the risk of tubal rupture, do not 4) Hick et al. Am J Emerg Med. 2001;19:488
do a pelvic exam on a patient who has had
5) Dart et al. Ann Emerg Med. 1999;33(3):283
MTX treatment and presents with pain or
vaginal bleeding,. Begin workup for ectopic 6) Stein et al. Ann Emerg Med. 2010;56(6):674
rupture and consult OB/GYN.** S UB S CR IBE TO E M C AS ES